NASDAQ:NVAX

Novavax Stock Insider Trading

Healthcare > Biotechnology

Buy NVAX

*Your capital is at risk

$10.20

-0.0100 (-0.0979%)

At Close: Jun 03, 2026

Novavax Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 89.43. In total, the insiders bought 5.36M and sold 383.02K NVAX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	89.43
● Buy	5.36M shares
● Sell	383.02K shares
83% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence Mar 03, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 89.43. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 01, 2026 Sell	Restricted Stock Units D-Return	Kelly James Patrick EVP, CFO And Treasurer	C-Suite Officer	58 666 Value: $0
Mar 01, 2026 Sell	Common Stock F-InKind	Kelly James Patrick EVP, CFO And Treasurer	C-Suite Officer	28 366 Value: $287.6K
Mar 01, 2026 Buy	Common Stock M-Exempt	Jacobs John C President And CEO	CEO / President	83 333 Value: $850.0K
Mar 01, 2026 Sell	Common Stock F-InKind	Jacobs John C President And CEO	CEO / President	38 450 Value: $389.9K
Mar 01, 2026 Buy	Restricted Stock Units M-Exempt	Jacobs John C President And CEO	CEO / President	83 333 Value: $850.0K
Mar 01, 2026 Buy	Common Stock M-Exempt	Kelly James Patrick EVP, CFO And Treasurer	C-Suite Officer	58 666 Value: $598.4K
Mar 01, 2026 Buy	Common Stock M-Exempt	Casey Mark J EVP, Chief Legal Officer	Officer	4 000 Value: $40.8K
Mar 01, 2026 Sell	Common Stock F-InKind	Casey Mark J EVP, Chief Legal Officer	Officer	1 214 Value: $12.3K
Mar 01, 2026 Buy	Restricted Stock Units M-Exempt	Casey Mark J EVP, Chief Legal Officer	Officer	4 000 Value: $40.8K
Jan 23, 2026 Buy	Common Stock M-Exempt	Jacobs John C President And CEO	CEO / President	83 197 Value: $762.9K
Jan 23, 2026 Sell	Common Stock F-InKind	Jacobs John C President And CEO	CEO / President	39 132 Value: $358.8K
Jan 23, 2026 Buy	Restricted Stock Units M-Exempt	Jacobs John C President And CEO	CEO / President	83 197 Value: $762.9K
Dec 11, 2025 Buy	Restricted Stock Units M-Exempt	Casey Mark J EVP, Chief Legal Officer	Officer	41 899 Value: $280.5K
Dec 11, 2025 Sell	Common Stock F-InKind	Casey Mark J EVP, Chief Legal Officer	Officer	12 713 Value: $85.0K
Dec 11, 2025 Buy	Common Stock M-Exempt	Casey Mark J EVP, Chief Legal Officer	Officer	41 899 Value: $280.5K
Nov 11, 2025 Sell	Common Stock F-InKind	Draghia-akli Ruxandra Section 16	Officer	6 048 Value: $44.8K
Nov 11, 2025 Buy	Common Stock M-Exempt	Draghia-akli Ruxandra Section 16	Officer	14 257 Value: $106.1K
Nov 11, 2025 Sell	Restricted Stock Units D-Return	Draghia-akli Ruxandra Section 16	Officer	14 257 Value: $0
Oct 29, 2025 Buy	Restricted Stock Units M-Exempt	Rodgers Richard J Director	Director	3 800 Value: $31.8K
Oct 29, 2025 Buy	Common Stock M-Exempt	Rodgers Richard J Director	Director	3 800 Value: $31.8K
Jun 20, 2025 Buy	Stock Option (Right to Buy) A-Award	Rodgers Richard J Director	Director	28 326 Value: $181.9K
Jun 20, 2025 Buy	Restricted Stock Units A-Award	Rodgers Richard J Director	Director	18 884 Value: $121.0K
Jun 20, 2025 Buy	Stock Option (Right to Buy) A-Award	Mott David M Director	Director	28 326 Value: $181.9K
Jun 20, 2025 Buy	Restricted Stock Units A-Award	Mott David M Director	Director	18 884 Value: $121.0K
Jun 20, 2025 Buy	Stock Option (Right to Buy) A-Award	King Rachel K. Director	Director	28 326 Value: $181.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVAVAX INC

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...

Read Full Profile Here